Trinity Biotech Files 2024 Annual Report and AGM Notice
Ticker: TRIB · Form: 6-K · Filed: Sep 8, 2025 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, agm, shareholder-notice
TL;DR
Trinity Biotech dropped its 2024 annual report and AGM docs, check it out.
AI Summary
Trinity Biotech plc filed a Form 6-K on September 8, 2025, to furnish its 2024 Annual Report as Exhibit 99.1. The filing also includes a "Letter from the Company Secretary," a "Notice of Annual General Meeting," and a "Form of Proxy" sent to holders of its Ordinary Shares. This report is incorporated by reference into Trinity Biotech's existing Form S-8 Registration Statements.
Why It Matters
This filing provides shareholders with the company's latest annual performance and details for the upcoming Annual General Meeting, allowing them to stay informed and participate in corporate governance.
Risk Assessment
Risk Level: low — This is a routine filing of annual reports and meeting notices, not indicating new financial distress or significant operational changes.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 2024 (date) — Annual Report Year
- September 8, 2025 (date) — Filing Date
- Form S-8 (document) — Incorporation by Reference
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to furnish Trinity Biotech plc's 2024 Annual Report as Exhibit 99.1 and to provide notice of the Annual General Meeting and related proxy materials to shareholders.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on September 8, 2025.
What specific documents are included with this filing?
The filing includes the Trinity Biotech plc Annual Report 2024, a "Letter from the Company Secretary," a "Notice of Annual General Meeting," and a "Form of Proxy."
Which registration statements does this filing get incorporated into?
This Form 6-K is incorporated by reference into Trinity Biotech plc's Registration Statements on Form S-8, specifically File Nos. 333-182279, 333-195232, and 333-253070.
What is the company's principal executive office address?
The company's principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Filing Stats: 252 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2025-09-08 06:03:02
Filing Documents
- zk2533762.htm (6-K) — 12KB
- exhibit_99-1.htm (EX-99.1) — 5460KB
- exhibit_99-2.htm (EX-99.2) — 17KB
- exhibit_99-3.htm (EX-99.3) — 22KB
- exhibit_99-4.htm (EX-99.4) — 21KB
- image00001.jpg (GRAPHIC) — 345KB
- 0001178913-25-003264.txt ( ) — 6008KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ John Gillard John Gillard Chief Executive Officer Date: September 8, 2025